Activation of the JAK‐STAT pathway is a well‐known model of tumorigenesis in chronic myeloproliferative diseases and certain leukemias 9, but the role of STAT5 in lymphocyte development and transformation is not so well understood. Here, STAT5A is linked to leukemia.